Crunchbase

Start Free Trial

Pricing

Instacart

Product Launch

Instacart Reports Agentic AI Assistant Drives Bigger Grocery Orders

Temasek

Growth Prediction

It is very likely that Temasek will grow

Quantinuum

Growth Insight

Quantinuum reported revenue of $30.93 million in 2025, an increase from $23 million in 2024, reflecting a year-over-year growth of approximately 34%. However, the company faced significant financial challenges, reporting a net loss of $192.6 million in 2025, which widened from a loss of $144.1 million in 2024. In the first quarter of 2026, Quantinuum's revenue fell sharply to $5.24 million, down from $19.1 million in the same quarter of the previous year, indicating a 73% decline. The company raised approximately $1.68 billion through its IPO by selling 28 million Class A shares at $60 each, which was above the initially expected range, reflecting strong investor demand. This IPO marked a significant milestone for Quantinuum, valuing the company at around $15.7 billion at its market debut.

xAI

Growth Prediction

It is probable that xAI will grow

Onit

Leadership Hire

Sports Business Daily: Executive Transactions - June 19, 2026

MoonPay

Growth Prediction

It is probable that MoonPay will grow

Denver Ventures

Investor Insight

Denver Ventures invests in seed and early-stage software, AI, manufacturing, and data-focused companies concentrated in Denver, Boulder, and Golden, Colorado, United States.

OpenAI

Growth Prediction

It is probable that OpenAI will grow

Bose

Award

The results are in: See the most-loved headphone and speaker brands

Franklin Templeton

Growth Prediction

It is very likely that Franklin Templeton will grow

DevvStream Holdings

Growth Insight

DevvStream entered into a binding term sheet with EEME Energy SPV I for a $6 million private placement of Series A non-redeemable convertible preferred stock, of which $1.5 million has already been funded to support its planned business combination with Southern Energy Renewables. Additionally, DevvStream completed a $250,000 private placement with an institutional investor, issuing 250,025 pre-funded warrants at $0.9999 each to bolster working capital. Furthermore, Helena Partners provided DevvStream with a new $700,000 zero-interest loan due March 2027 to support the company’s working capital needs. The company also confirmed that its three-party Business Combination Agreement with Southern Energy Renewables and XCF Global remains in effect, and they are proceeding toward completing the proposed combination.

European Bank for Reconstruction and Development

Growth Prediction

It is probable that European Bank for Reconstruction and Development will grow

L3Harris Technologies

Product Launch

L3Harris Delivers VC-25B Aircraft to US Air Force

Mistral AI

Growth Prediction

It is probable that Mistral AI will grow

New Stack Ventures

Investor Insight

New Stack Ventures invests in seed to early-stage companies in software, fintech, and information technology, with activity across Boston, Denver, and Scottsdale in the United States.

Cohere

Growth Prediction

It is probable that Cohere will grow

NatWest Group

Layoff

NatWest CEO Says AI Will Take Over Some Existing Banking Roles

Harvey

Growth Prediction

It is very likely that Harvey will grow

CME Group

Growth Insight

CME Group reported record open interest and average daily volume in its Dairy futures and options, indicating increased customer usage of these products. The company also reported record open interest of 36.3 million contracts in its U.S. Treasury futures and options, reflecting growing client participation in these markets. In January 2026, CME Group experienced a 15% year-over-year increase in average daily volume to a record 29.6 million contracts, indicating higher customer trading activity across asset classes. Additionally, CME Group reported record single-day trading activity in its natural gas futures and options complex, indicating a significant increase in active clients and usage of these contracts. For Q4 2025, CME Group reported earnings per share of $2.77 on revenue of $1.65 billion, exceeding analyst expectations. The company's adjusted profit for the fourth quarter rose to $997.7 million from $907.4 million a year earlier, reflecting stronger trading volumes and higher revenue. CME Group's net income for 2025 increased to $4.07 billion from $3.53 billion in 2024, with diluted EPS rising to $11.16 from $9.67. In Q1 2026, net income rose to $1.15 billion from $0.96 billion a year earlier, reflecting a roughly 21% year-over-year increase in profitability. CME Group's Q1 2026 revenue increased 14% year over year to $1.88 billion from $1.64 billion, reflecting strong trading activity across asset classes. The company reported record Q1 2026 revenue of $1.9 billion, a 14% increase over the same quarter in 2025. CME Group also reported higher fourth-quarter revenue, with market data revenue up 14.5% to $208 million and clearing and transaction fees up 7.8% to $1.33 billion from a year earlier, driven by increased trading volumes amid heightened hedging demand.

European Investment Bank

Growth Prediction

It is very likely that European Investment Bank will grow

OpenClaw

Award

Yann LeCun, fondateurs d’Alibaba et OpenClaw… : qui a remporté les premiers «Oscars de la tech» à VivaTech ?

Cyera

Growth Prediction

It is probable that Cyera will grow

Avesta Fund

Investor Insight

Avesta Fund invests in seed and early-stage companies in artificial intelligence, software, cleantech, and energy-related data and analytics, focusing on New York, Denver, and San Francisco in the United States.

Sierra

Growth Prediction

It is very likely that Sierra will grow

Sony

Award

The results are in: See the most-loved headphone and speaker brands

Andreessen Horowitz

Growth Prediction

It is probable that Andreessen Horowitz will grow

Cartesian Therapeutics

Growth Insight

Cartesian Therapeutics reported a total revenue decline from $1.1 million in the first quarter of 2025 to $78,000 in the first quarter of 2026, reflecting lower collaboration and grant revenue. The company also experienced a widening net loss, which increased to $39.2 million in the first quarter of 2026 from $17.7 million a year earlier, attributed to higher R&D spending and a loss on change in fair value of a contingent value right liability. Additionally, Cartesian Therapeutics secured a non-dilutive credit facility of up to $150 million from K2 HealthVentures, with an initial $50 million tranche to extend runway through key Phase III AURORA trial milestones. The company raised approximately $14.6 million in gross proceeds during Q1 2026 through its at-the-market equity offering program to support ongoing operations and clinical trials.

Perplexity

Acquisition Prediction

It is very likely that Perplexity will be acquired

Meridian Credit Union

Partnership Announcement

New Survey Finds Canadians See Opportunity to Strengthen Support for Young Adults Entering the Workforce

Perplexity

Growth Prediction

It is probable that Perplexity will grow

Draper Associates

Investor Insight

Draper Associates invests in seed and early-stage AI, software, and biotechnology companies, primarily in North America with selective activity in South America.

Oura

Growth Prediction

It is probable that Oura will grow

ArmorCode

Product Launch

New infosec products of the week: June 19, 2026

Plug and Play

Growth Prediction

It is very likely that Plug and Play will grow

Intuitive

Growth Insight

Intuitive Surgical reported a 23% year-over-year increase in revenue for Q1 2026, amounting to $2.77 billion, driven by higher surgical procedure volumes and more da Vinci system placements. For the full year 2025, the company achieved approximately $10.06 billion in revenue, reflecting a 21% increase compared to $8.35 billion in 2024. The number of da Vinci robotic-assisted surgical procedures increased by 18% year-over-year in Q4 2024, and the total procedures performed worldwide reached approximately 2.29 million in 2023, a 22% increase over 2022. The installed base of da Vinci systems grew to 11,395 worldwide at the end of Q1 2026, marking a 12% year-over-year rise. Additionally, Intuitive Surgical's GAAP net income for Q4 2025 rose to $795 million from $686 million in Q4 2024, with diluted EPS increasing from $1.88 to $2.21.

Lightspeed Venture Partners

Growth Prediction

It is very likely that Lightspeed Venture Partners will grow

Zetane Systems

Product Launch

Scale AI's Mission to VivaTech 2026: Strengthening Multinational Partnerships With Trusted Allies

World Labs

Growth Prediction

It is probable that World Labs will grow

Tribe Capital

Investor Insight

Tribe Capital backs seed to late-stage companies in software, AI, and fintech, investing across San Francisco and Mexico City in North America and Singapore in Asia.

Lovable

Growth Prediction

It is very likely that Lovable will grow

ZeroKey

Product Launch

Scale AI's Mission to VivaTech 2026: Strengthening Multinational Partnerships With Trusted Allies

Suno

IPO Prediction

It is probable that Suno will IPO

SoundHound

Growth Insight

SoundHound AI reported significant growth in its revenue, nearly doubling to $168.9 million in 2025, reflecting a 99% year-over-year increase compared to 2024. The company achieved a revenue increase of 59% year-over-year in the fourth quarter of 2025, with revenue reaching $55.1 million. Additionally, SoundHound AI's revenue for the first quarter of 2026 increased by 52% year-over-year to $44.2 million, driven by strong demand for its voice and agentic AI solutions. The installed base of monthly users in its automotive business grew by more than 50% year-over-year, indicating rapid adoption of its in-car voice AI solutions. Furthermore, the company ended the latest quarter with $216 million in cash and equivalents and no debt, providing a buffer to fund ongoing losses while it pursues growth.

Honor

Growth Prediction

It is probable that Honor will grow

Yandex.Market

Product Launch

Яндекс Маркет снизил комиссию для продавцов одежды и обуви — ставка упала более чем втрое

RA Capital Management

Growth Prediction

It is very likely that RA Capital Management will grow

Alibaba Group

Investor Insight

Alibaba Group invests in early-stage and growth companies in AI, foundational AI, and software, focusing on Haidian, Beijing; Shanghai, China; and Singapore in Asia.

Blackstone Credit

Growth Prediction

It is very likely that Blackstone Credit will grow

Visual Comfort & Co.

Product Launch

Visual Comfort & Co. Announces New Design Partnership with Richard June

General Atlantic

Growth Prediction

It is very likely that General Atlantic will grow

Venture Global

Growth Insight

Venture Global reported a significant increase in its financial performance, with Q1 2026 earnings per share reaching $0.19, surpassing analyst expectations of $0.12. The company also reported a 24.2% year-over-year increase in Q4 earnings per share, which rose to $0.41, exceeding the consensus estimate of $0.35. For the full year 2025, net income increased to $2.26 billion from $1.48 billion in 2024, marking a 53% rise driven by higher LNG sales volumes. In Q1 2026, net income grew to $598 million from $502 million year-over-year, reflecting strong profitability growth alongside record LNG export volumes. Additionally, Venture Global raised its full-year EBITDA guidance for 2026 to a range of $8.2 billion to $8.5 billion, up from a previous range of $5.2 billion to $5.8 billion, indicating stronger expected profitability due to higher LNG prices and expanded contracted volumes. The company also secured $8.6 billion in project financing for the second phase of its CP2 LNG project, contributing to a total CP2 financing of $20.7 billion.

Apollo.io

Growth Prediction

It is probable that Apollo.io will grow

umo

Product Launch

UMO впервые возглавил рынок электромобилей в России — на бренд пришлось 35% продаж в мае 2026-го

Antler

Growth Prediction

It is very likely that Antler will grow

Saison Capital

Investor Insight

Saison Capital invests in seed and early-stage fintech, financial services, and blockchain companies across Asia, with activity in Singapore, India, and Indonesia.

Linux Foundation

Growth Prediction

It is very likely that Linux Foundation will grow

NASCAR

Partnership Announcement

And the Academy Award goes to ... NASCAR?

Kalshi

IPO Prediction

It is probable that Kalshi will IPO

Oasis Security

Growth Insight

Oasis Security reported strong enterprise adoption with new annual recurring revenue growing 5x year over year, driven largely by multi-year enterprise agreements with Fortune 500 customers. The company raised $120 million in a Series B funding round led by Craft Ventures, with participation from existing investors Cyberstarts, Sequoia Capital, and Accel, bringing its total funding to $195 million. This funding was aimed at scaling its non-human identity security platform for AI agents and machine accounts.

Kalshi

Growth Prediction

It is very likely that Kalshi will grow

Robosen

Product Launch

Robosen Buzz Lightyear: más allá de la robótica

Alumni Ventures

Growth Prediction

It is very likely that Alumni Ventures will grow

Sumitomo Corporation Equity Asia

Investor Insight

Sumitomo Corporation Equity Asia invests in early to late-stage software, IT, logistics, and transportation companies, focusing on Singapore, Malaysia, and the United States within Asia and North America.

Nuveen

Growth Prediction

It is probable that Nuveen will grow

Xiaoi Robot

Legal Proceeding

Xiao-I Corporation Provides Update on First-Instance Rulings in Patent Litigation Against Apple; Company Intends to Appeal to the Supreme People's Court

Legora

Acquisition Prediction

It is probable that Legora will be acquired

Freenome

Growth Insight

Freenome secured a $75 million equity investment from Roche as part of a larger $200 million licensing deal to commercialize its test kits outside the US. During Q1 2024, Freenome secured USD 254 million in funding to further develop its early disease detection platform. Freenome reported an R&D milestone with improved clinical performance of an updated version of its SimpleScreen CRC blood test, showing 85% sensitivity for colorectal cancer and enhanced detection of advanced precancerous lesions in a nearly 1,000-sample validation study. Freenome also reported initial development results for its multiomic investigational lung cancer screening test, showing high adjusted sensitivity and outperforming a methylation-only version in a 673-sample evaluation cohort.

Nscale

IPO Prediction

It is probable that Nscale will IPO

Genesis

Product Launch

VivaTech : les robots des startups européennes tentent de tirer leur épingle du jeu face aux géants chinois

Fin

Growth Prediction

It is very likely that Fin will grow

Y Combinator

Investor Insight

Y Combinator invests primarily in pre-seed, seed, and early-stage software, SaaS, and AI startups, with activity concentrated in San Francisco, New York, and London across North America and Europe.

Glean

Growth Prediction

It is very likely that Glean will grow

Ideabaaz

Partnership Announcement

BeyondSeed & Ideabaaz Unveil Rs 100 Cr Startup Investment Initiative

The Twenty Minute VC

Growth Prediction

It is probable that The Twenty Minute VC will grow

Terra Drone

Growth Insight

Terra Drone increased its revenue by 7.8% year on year to 4.78 billion JPY in fiscal year 2026.01, continuing its high growth trajectory. The company expanded its market presence through various partnerships, including a sales agency agreement with Green Sky Group for the Terra Xross 1 indoor inspection drone in Australia, and a partnership with Maverick Drone Systems for deployment in the US. Additionally, Terra Drone began real-world deployment of the Terra A2 fixed-wing interceptor drone in Ukraine and expanded its defense operations with the Terra A1 interceptor drone, which successfully engaged a long-range unmanned aircraft threat in a real operational environment. The company also achieved key R&D milestones, including successful inspections of deep sewer pipes and operational testing of its interceptor drones in combat environments.

Advent International

Growth Prediction

It is probable that Advent International will grow

Bang & Olufsen

Product Launch

Bang & Olufsen Revives A 1985 Hi-Fi Icon With A $30,000 Luxury Turntable

Advanced Machine Intelligence

Growth Prediction

It is very likely that Advanced Machine Intelligence will grow

Alpha Edison

Investor Insight

Alpha Edison backs seed to early-stage companies in software, AI, and financial services, primarily investing across Los Angeles, San Francisco, and Irvine in California, United States.

Anysphere (Cursor)

Growth Prediction

It is very likely that Anysphere (Cursor) will grow

St. Augustine Gold and Copper

Partnership Announcement

St. Augustine Announces the Appointment of ELD as Financial Advisor for the Advancement of the Kingking Copper-Gold Project

Rebellions

Growth Prediction

It is very likely that Rebellions will grow

Abbott

Growth Insight

Abbott Laboratories completed its acquisition of cancer diagnostics company Exact Sciences on March 23, 2026, for approximately $21 billion, integrating Exact Sciences into Abbott's healthcare portfolio. This acquisition aimed to expand Abbott's cancer screening and precision oncology diagnostics portfolio, including products like Cologuard and Cancerguard. In the first quarter of 2026, Abbott reported net sales of $11.164 billion, reflecting a 7.8% increase year over year from $10.358 billion in the same period of 2025. The company's diabetes care portfolio generated nearly $8 billion in revenue for FY2025, marking a 17.5% increase from FY2024. Abbott's full-year 2025 net sales rose to $44.328 billion from $41.95 billion in 2024, a 5.7% increase driven by strong growth in Medical Devices and Established Pharmaceuticals. Additionally, Abbott's adjusted earnings per share for the first quarter of 2026 were reported at $1.15, slightly above the consensus estimate of $1.14.

Entrepreneurs First

Growth Prediction

It is very likely that Entrepreneurs First will grow

Enabot

Product Launch

Hands-On: Enabot EBO Air 2 Plus FamilyBot

Stonepeak

Growth Prediction

It is very likely that Stonepeak will grow

Garage Capital

Investor Insight

Garage Capital backs seed to early-stage AI, software, and IT companies across North America, with key activity in Toronto, Montréal, and San Francisco.

Primary Venture Partners

Growth Prediction

It is very likely that Primary Venture Partners will grow

Accenture Song

Product Launch

Accenture Song is using Amazon data and AI to help measure ad performance across platforms

Agibot

Growth Prediction

It is probable that Agibot will grow

Signos

Growth Insight

Signos reported that its business grew more than 10x in the last six months, reflecting rapid scaling of its glucose monitoring platform for weight management. The company raised a $20 million funding round on May 27, 2026, backed by GV, Dexcom, and Blue Cross Blue Shield of Alabama, to support its metabolic health platform. This funding round brought Signos' total fundraising to $57 million since 2018. Additionally, Signos conducted a large clinical study with 35,000 participants on metabolism and weight loss, generating evidence that helped its glucose monitoring platform become the first FDA-cleared non-drug, non-surgical device for weight management.

Sigma Computing

Growth Prediction

It is very likely that Sigma Computing will grow

Crayola

Partnership Announcement

/C O R R E C T I O N — Crayola/

Thinking Machines Lab

Growth Prediction

It is very likely that Thinking Machines Lab will grow

Ride Home Fund

Investor Insight

Ride Home Fund backs seed to late-stage software and AI companies in information technology, focusing on investments in San Francisco, New York, and San Diego in the United States.

Fresha

Growth Prediction

It is probable that Fresha will grow

Vooban

Product Launch

Scale AI's Mission to VivaTech 2026: Strengthening Multinational Partnerships With Trusted Allies

Chainguard

Growth Prediction

It is very likely that Chainguard will grow

Teva Pharmaceuticals

Growth Insight

Teva Pharmaceutical Industries reported a revenue increase of 4% year over year in 2025, reaching approximately $17.3 billion, driven by strong sales of innovative drugs and milestone payments. The company generated free cash flow of $188 million in Q1 2026, up from $107 million in Q1 2025, reflecting improved operating cash flows. Teva's non-GAAP earnings per share for Q1 2026 was reported at $0.53, exceeding analyst expectations. Additionally, Teva's migraine drug AJOVY saw a 30% increase in sales in 2025, reaching $673 million, while sales of its Huntington's disease drug Austedo rose 34% to $2.26 billion. The company also reported that net sales of UZEDY increased by 63% year over year to $191 million in 2025.

Stripe

Growth Prediction

It is probable that Stripe will grow

Make better decisions, faster